1. Home
  2. DHI vs ONC Comparison

DHI vs ONC Comparison

Compare DHI & ONC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo D.R. Horton Inc.

DHI

D.R. Horton Inc.

HOLD

Current Price

$149.89

Market Cap

43.8B

ML Signal

HOLD

Logo BeiGene Ltd. American Depositary Shares

ONC

BeiGene Ltd. American Depositary Shares

HOLD

Current Price

$355.98

Market Cap

40.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DHI
ONC
Founded
1978
2010
Country
United States
Switzerland
Employees
N/A
12000
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
43.8B
40.6B
IPO Year
1995
2015

Fundamental Metrics

Financial Performance
Metric
DHI
ONC
Price
$149.89
$355.98
Analyst Decision
Hold
Strong Buy
Analyst Count
14
10
Target Price
$166.08
$385.10
AVG Volume (30 Days)
2.4M
406.3K
Earning Date
04-21-2026
05-06-2026
Dividend Yield
1.19%
N/A
EPS Growth
N/A
140.43
EPS
7.45
0.31
Revenue
$34,250,400,000.00
$238,387,000.00
Revenue This Year
$0.05
$723.76
Revenue Next Year
$5.85
$15.04
P/E Ratio
$19.57
$1,158.23
Revenue Growth
N/A
22179.16
52 Week Low
$131.75
$253.95
52 Week High
$183.62
$385.22

Technical Indicators

Market Signals
Indicator
DHI
ONC
Relative Strength Index (RSI) 50.83 73.69
Support Level $145.45 $305.66
Resistance Level $150.95 $371.94
Average True Range (ATR) 4.41 7.62
MACD 0.39 2.77
Stochastic Oscillator 69.54 81.60

Price Performance

Historical Comparison
DHI
ONC

About DHI D.R. Horton Inc.

D.R. Horton is the largest homebuilder in the United States with operations in 126 markets across 36 states. D.R. Horton mainly builds single-family homes (over 90% of home sales revenue) and offers products to entry-level, move-up, luxury buyers, and active adults. The company offers homebuyers mortgage financing and title agency services through its financial services segment. The firm has majority ownership of Forestar Group, a publicly traded residential lot development company. D.R. Horton's headquarters are in Arlington, Texas.

About ONC BeiGene Ltd. American Depositary Shares

Formerly known as BeiGene and founded in 2010 in Beijing, BeOne is a commercial-stage biotech firm that produces oncology therapeutics. The company's main product is Brukinsa, which is a small-molecule drug that treats multiple forms of Non-Hodgkin lymphoma and leukemia. The company conducts drug discovery, runs global clinical trials, and manufactures drugs independently. As of 2025, Brukinsa made up for 74% of total revenue, while it has two other approved commercialized drugs in its portfolio, Beqalzi and Tevimbra. While Brukinsa has a global leadership, the other two drugs generate revenue mostly from China. Based on Brukinsa, BeOne competes with AbbVie and AstraZeneca mainly. The company also has more than 50 drugs in clinical trials in its active pipeline, focused on other cancers.

Share on Social Networks: